Susquehanna International Group’s Genetic Technologies Ltd. GENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,617
| Closed | -$20.7K | – | 13637 |
|
|
2024
Q3 | $20.7K | Sell |
27,617
-49,686
| -64% | -$44.2K | ﹤0.01% | 11620 |
|
|
2024
Q2 | $115K | Buy |
77,303
+42,707
| +123% | +$96.1K | ﹤0.01% | 10915 |
|
|
2024
Q1 | $100K | Buy |
+34,596
| New | +$79.5K | ﹤0.01% | 11217 |
|
|
2023
Q1 | – | Sell |
-15,376
| Closed | -$70K | – | 13763 |
|
|
2022
Q4 | $70K | Buy |
15,376
+9,180
| +148% | +$52K | ﹤0.01% | 11219 |
|
|
2022
Q3 | $37K | Sell |
6,196
-4,145
| -40% | -$30.2K | ﹤0.01% | 12373 |
|
|
2022
Q2 | $59K | Buy |
10,341
+3,762
| +57% | +$27.2K | ﹤0.01% | 11878 |
|
|
2022
Q1 | $65K | Buy |
6,579
+1,187
| +22% | +$11.5K | ﹤0.01% | 12178 |
|
|
2021
Q4 | $51K | Sell |
5,392
-1,642
| -23% | -$21K | ﹤0.01% | 12533 |
|
|
2021
Q3 | $108K | Sell |
7,034
-3,071
| -30% | -$52.7K | ﹤0.01% | 12027 |
|
|
2021
Q2 | $215K | Sell |
10,105
-3,400
| -25% | -$68.6K | ﹤0.01% | 11452 |
|
|
2021
Q1 | $282K | Sell |
13,505
-1,597
| -11% | -$36.5K | ﹤0.01% | 10750 |
|
|
2020
Q4 | $272K | Buy |
15,102
+4,439
| +42% | +$73.3K | ﹤0.01% | 9467 |
|
|
2020
Q3 | $184K | Buy |
+10,663
| New | +$199K | ﹤0.01% | 9525 |
|
|
2019
Q2 | – | Sell |
-9,564
| Closed | -$170K | – | 10981 |
|
|
2019
Q1 | $170K | Buy |
9,564
+1,956
| +26% | +$32.5K | ﹤0.01% | 7969 |
|
|
2018
Q4 | $82K | Buy |
7,608
+5,607
| +280% | +$116K | ﹤0.01% | 8304 |
|
|
2018
Q3 | $44K | Buy |
2,001
+603
| +43% | +$13.7K | ﹤0.01% | 8882 |
|
|
2018
Q2 | $27K | Sell |
1,398
-3,342
| -71% | -$79.1K | ﹤0.01% | 9389 |
|
|
2018
Q1 | $99K | Buy |
4,740
+3,678
| +346% | +$106K | ﹤0.01% | 8708 |
|
|
2017
Q4 | $25K | Sell |
1,062
-24,076
| -96% | -$453K | ﹤0.01% | 9045 |
|
|
2017
Q3 | $418K | Sell |
25,138
-2,484
| -9% | -$41.4K | ﹤0.01% | 6826 |
|
|
2017
Q2 | $498K | Sell |
27,622
-4,348
| -14% | -$91.1K | ﹤0.01% | 6651 |
|
|
2017
Q1 | $761K | Sell |
31,970
-14,198
| -31% | -$324K | ﹤0.01% | 5703 |
|
|
2016
Q4 | $997K | Buy |
+46,168
| New | +$1.28M | ﹤0.01% | 5545 |
|
|
2013
Q4 | – | Sell |
-114
| Closed | -$26K | – | 9441 |
|
|
2013
Q3 | $26K | Hold |
114
| – | – | ﹤0.01% | 8303 |
|
|
2013
Q2 | $27K | Buy |
+114
| New | +$29.6K | ﹤0.01% | 8063 |
|
Other funds holding GENE
Susquehanna International Group's GENE Position: Q4 2024 in Review
Susquehanna International Group sold out of Genetic Technologies Ltd. (GENE) in Q4 2024, closing a stake of 27,617 shares — an estimated $20.7K sold.
Susquehanna International Group first reported a position in GENE in Q2 2013 and held it in 25 quarters. The position peaked at $997K in Q4 2016. 1 fund tracked by Wall St. Rank holds GENE as of Q4 2024.
- Susquehanna International Group reported no remaining Genetic Technologies Ltd. position as of Q4 2024 after selling out during the quarter.
- Susquehanna International Group sold 27,617 Genetic Technologies Ltd. shares in Q4 2024, an estimated $20.7K.
- Susquehanna International Group first reported a position in Genetic Technologies Ltd. in Q2 2013 and held it in 25 quarters.
- Susquehanna International Group's Genetic Technologies Ltd. position peaked at $997K in Q4 2016.
- 1 fund tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2024.
Based on Susquehanna International Group's 13F filing for Q4 2024, filed 14 Feb 2025.